Presented by

BPCI BPCI
IPHA IPHA
NIBRT NIBRT

Event sponsors

PWC PWC

Pharma Patrons

Alexion

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies.

Since its founding in 1992, Alexion has given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives are at stake.
Alexion has 3,000 passionate and dedicated employees serving patients in 50 countries around the world. Alexion’s investment in Ireland is one of the largest healthcare investments in the country. Alexion is investing in the future of Ireland and offers employment opportunities at the cutting edge of science and innovation, with currently > 600 highly skilled & talented people employed in our 2 sites.

Our state-of-the-art facilities in Ireland allow us to produce and export life-transforming treatments to our patients globally
The College Park site, home to >400 people, is a multi-capability site with Bulk Drug Substance Manufacturing, Commercial & Clinical Secondary Packaging, QC Global Centre of Excellence, Quality Assurance Release & Certification, External CMO Management, Global Supply Chain, Finance, HR and IT Functions
The Athlone site, home to >200 people, has capabilities in Aseptic Drug Product Manufacturing, Commercial Drug Substance Purification and Clinical Drug Substance Manufacturing


Astellas

Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 16,000 people globally. A young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through providing innovative and reliable pharmaceutical products. Astellas’ key strengths lie in the therapy areas of Transplantation, Urology and Oncology.
Formed in 2005 through the merger of Yamanouchi and Fujisawa, Astellas continues to remain committed to developing first-in-class and best-in-class products. With significant ongoing investment in R&D, Astellas continues to strengthen its capabilities as a research-driven pharmaceutical company, bringing effective therapies to patients around the world and continuing to build trusted networks amongst physicians and partners. With healthcare is in an era of unprecedented change and progress, new scientific discoveries combined with advances in technology are deepening our understanding of disease and creating an array of potential new medical solutions. Our vision is to be on the forefront of this changing healthcare environment, turning innovative science into valuable new treatment options for patients.
In Ireland Astellas employs nearly 400 people. Based across two manufacturing sites in Killorglin, Co.Kerry and Mulhuddart, Co.Dublin. and a sales and marketing office in Citywest Dublin, Astellas has a long-standing reputation in Ireland.


Eli Lilly

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Lilly has been in Ireland for over 35 years and employs over 1,000 people across a range of activities including biopharmaceutical manufacturing and commercialisation, global business services, marketing and sales.

At our manufacturing campus in Kinsale, Lilly employs over 700 people, making medicine using the most modern chemical synthesis & biotechnology manufacturing processes. Lilly Kinsale makes medicines for the treatment of illnesses across therapeutic areas including oncology, immunology and diabetes. Recently in Kinsale, Lilly CEO David Ricks opened an active ingredient continuous manufacturing facility, which is designed to manufacture the most innovative small molecule medicines that are currently in the company’s development pipeline. The company is also investing in a significant expansion to the biotechnology capacity at the site, which is targeted for completion in 2021.

Our global business solutions centre in Little Island, Co. Cork employs over 400 people providing centralised business services to the company globally, including travel services, financial services and medical information support. The centre is currently expanding operations to include a wide range of innovative new services and is in the process of constructing a new office block that will double the size of its existing footprint.

To learn more about Lilly, please visit us at www.lilly.com / www.lilly.ie


Innopharma Group

Innopharma are a group of companies who work together to bring the future of manufacturing forward.

Our technology, education and services divisions are leading the way in the development of solutions, learning and people to progress the world’s pharmaceutical industry through advanced skills and technologies.


Janssen

At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we are uniquely positioned and privileged to make a positive difference to the lives of patients and their loved ones, at all stages of life. In Ireland, we employ over 800 dedicated individuals1 across our commercial and manufacturing sites in Dublin and Cork who are inspired to help find new and better ways to prevent, intercept, treat and cure some of the most complex medical challenges of our time.
Building on over 100 years of scientific heritage, we focus our efforts on developing transformational treatments for patients across six distinct areas of healthcare:
Oncology
Neuroscience
Infectious diseases and vaccines
Immunology
Cardiovascular and metabolic diseases
Pulmonary hypertension.
We bring together the best minds and pursue the most promising science to solve problems and find solutions for diseases where the unmet need is great.
Driven by the Johnson & Johnson Credo alongside our enduring commitment to patients and their families, our people and our local communities - we work in trusted, transparent partnerships with patient organisations, healthcare professionals and the Health Service Executive to make a real difference where it matters most. We have been involved in some of the biggest breakthroughs in medicine since we first arrived in Ireland. We want Ireland and Irish patients to benefit from the breakthroughs we will make over the decades to come. That is why we are here.
We are Janssen. We are working to create a world without disease. To learn more, visit our website: www.janssen.com/ireland


Mallinckrodt

Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.


MSD

MSD Ireland is one of the country’s leading healthcare companies, having first established here over 50 years ago. We currently employ approximately 2,300 employees, across five sites in Ballydine, Co Tipperary, Brinny, Co Cork, Carlow and Dublin and, in addition, operate substantial Human Health and Animal Health businesses. In total to date, we have invested $2.5 billion in our Irish operations and our annual turnover ranks us as one of Ireland’s top 20 companies. Our Irish sites manufacture approximately half of MSD’s top twenty products, saving and enhancing lives in over sixty countries around the world.


Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life


Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader committed to bringing better health and a brighter future to patients by translating science into life-changing medicines, has been established in Ireland since 1997. Across Ireland, Takeda has commercial operations, corporate services and three manufacturing facilities in Bray, Dunboyne and Grange Castle.



Close